NCT05569044
Recruiting
Not Applicable
Effects of Oral Rehydration Solutions in Healthy Adult Athletes
ConditionsHydration
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hydration
- Sponsor
- Abbott Nutrition
- Enrollment
- 24
- Locations
- 1
- Primary Endpoint
- Anaerobic Power
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
This is a prospective, randomized, controlled, crossover study to determine the benefits of adult athletes consuming an oral rehydration solution (ORS) with exercise.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 to 30 years of age.
- •Body fat percentage ≤17% for males and ≤24% for females.
- •Male or non-pregnant, non-lactating female, at least 6 months postpartum prior to screening visit.
- •Cycling VO2max in range of 45-53 mL O2/kg/min for males or 36-43 mL O2/kg/min for females.
- •If female, participant has a regular menstrual cycle, \>21 days and \<35 days in length.
- •Willing to consume grape-flavored beverages during the study.
- •If on chronic medication such as lipid-lowering, thyroid medication or hormone therapy, the dosage must be constant for at least 2 months prior to screening and baseline visit.
- •Weight-stable for the two months prior to screening visit
- •Voluntarily signed and dated an informed consent form (ICF), approved by an IRB, and provided Health Insurance Portability and Accountability Act (HIPAA) or other applicable privacy regulation authorization prior to any participation in the study.
- •No known intolerance or allergy to ingredients in study products.
Exclusion Criteria
- •Athlete in a weight-conscious sport such as but not limited to wrestling, powerlifting, boxing, rowing, gymnastics or any martial arts.
- •Currently, and for the past 4 weeks or longer: running \>40 miles per week on average, cycling \>80 miles per week on average or swimming \>20,000 yards per week on average.
- •Participating in another study that has not been approved as a concomitant study.
- •Uses any form of tobacco or nicotine, or other controlled substance not prescribed by a physician.
- •Previous history with heat illness or injury that resulted in a visit to a medical center.
- •Experienced a serious musculoskeletal injury or surgery in the past 6 months that poses a risk during the trial, according to the study investigator.
- •Eating disorder, severe dementia or delirium, history of significant neurological or psychiatric disorder, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures.
- •Currently taking or has taken antibiotics within 6 weeks of enrollment.
- •Currently taking or has taken a diuretic within 1 week of enrollment.
- •Diagnosed with the following according to medical records, self-report or according to the clinician's judgment:
Outcomes
Primary Outcomes
Anaerobic Power
Time Frame: Through Study completion, an average of 6 weeks
Change in cycling power
Secondary Outcomes
- Body Mass(Through Study completion, an average of 6 weeks)
- Muscular Force(Through Study completion, an average of 6 weeks)
- Rating of Perceived Exertion (RPE)(Through Study completion, an average of 6 weeks)
- Power Output(Through Study completion, an average of 6 weeks)
- Leg Strength(Through Study completion, an average of 6 weeks)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Oral Rehydration Solution in Healthy AdultsDehydrationNCT06130475Abbott Nutrition26
Terminated
Not Applicable
Oral Rehydration Solution and Dehydration RecoveryDehydrationNCT06368765Abbott Nutrition9
Completed
Phase 4
Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute GastroenteritisDiarrheaNCT01467570Medical University of Warsaw147
Recruiting
Not Applicable
Study about the effectiveness of oral rehydration therapy for acute gastroenteritis in children.acute gastroenteritisJPRN-UMIN000013337Saiseikai Yokohamasi Nanbu Hospital100
Completed
Phase 2
Isoleucine Added ORS in Children With DiarrhoeaAcute Infectious Diarrhoea in ChildrenNCT01034228International Centre for Diarrhoeal Disease Research, Bangladesh50